Wellington Management Group LLP Homology Medicines, Inc. Transaction History

Wellington Management Group LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $1.58 Million - $2.54 Million	-607,968 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$3.64 - $7.78 $634,204 - $1.36 Million	-174,232 Reduced 22.27%	607,968 $2.21 Million
Q3 2021 Nov 15, 2021	SELL	$6.01 - $8.71 $9.68 Million - $14 Million	-1,610,438 Reduced 67.31%	782,200 $6.16 Million
Q2 2021 Aug 16, 2021	BUY	$6.02 - $9.64 $690,602 - $1.11 Million	114,718 Added 5.04%	2,392,638 $17.4 Million
Q1 2021 May 17, 2021	BUY	$9.17 - $14.8 $1.24 Million - $2 Million	134,938 Added 6.3%	2,277,920 $21.4 Million

Q4 2020 Feb 12, 2021	BUY	$8.92 - $13.29 $5.67 Million - $8.45 Million	636,163 Added 42.22%	2,142,982 $24.2 Million
Q3 2020 Nov 16, 2020	BUY	$9.94 - $16.59 $10.9 Million - $18.1 Million	1,092,106 Added 263.34%	1,506,819 $16.1 Million
Q2 2020 Aug 14, 2020	BUY	$12.07 - $19.34 $5.01 Million - $8.02 Million	414,713 New	414,713 $6.3 Million
Q1 2020 May 14, 2020	SELL	$12.5 - $22.04 $5.63 Million - $9.93 Million	-450,760 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$11.42 - $22.19 $5.15 Million - $10 Million	450,760 New	450,760 $9.33 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.